Raritan, N.J. – November 2, 2010 — iContracts, a leading provider of solutions for managing corporate contracts, commitments, and compliance today announced that Silarx Pharmaceuticals, Inc., a manufacturer of quality generic liquid pharmaceutical products, has gone live on solutions from iContracts to manage commercial contracts, help insure Government Pricing compliance, and analyze contract performance. iContracts’ entire suite of solutions are based on the company’s Better Contracting Solutions (BCS) platform, available on-demand or behind-the-firewall, and will help Silarx manage these intricate processes in a unified environment with a high degree of automation.
Joe D. Hampton, Jr., Senior VP of Silarx, commented “Silarx is thrilled to have successfully completed its initial phase of the iContracts implementation, which primarily focused on contract management and chargeback processes. What was once a timely and exasperating process, is now replaced by iContracts highly automated, completely web-based suite of solutions which will support our growth for years to come. We have been very impressed with the knowledge and professionalism of the iContracts team and look forward to expanding our relationship over the next few years.”
iContracts CEO, A. Leigh Powell, remarked, “We have been thoroughly impressed with the entire Silarx team and their focus on quickly implementing iContracts’ leading solutions to both drive value and prepare for rapid growth in the coming years. iContracts is committed to building on this success as Silarx implements additional components of our Better Contracting Solutions platform over the coming months.”
About iContracts
iContracts’ goal is simple – to deliver better solutions for managing contracts that are faster, easier and less expensive to implement. This mantra is reflected in everything we do. Our software is far ahead of other solutions. Powered by a Simplified Common User Interface (SCUI) that makes every user an “expert” by learning just two simple, reusable views and is backed by a highly evolved data architecture – built by technologists with considerable and unique experience in building contract management solutions for the Life Sciences industry. This deep understanding and straightforward approach shows in everything we do. iContracts’ comprehensive suite of solutions manages all aspects of a Life Science company’s chargeback, rebate and Medicaid processes as well as other incentive agreements and Government Pricing compliance at all levels. Our solutions are enterprise-class and can be easily integrated with any off-the-shelf or custom system to meet exacting business requirements without the army of consultants and endless fees associated with other products and providers. For more information, please visit www.icontracts.com.
About Silarx
Silarx Pharmaceuticals, Inc. is a manufacturer and marketer of quality generic liquid pharmaceutical products. Since 1987, dedication to quality manufacturing and marketing has allowed Silarx Pharmaceuticals to experience steady growth in the category of liquid generic drug products.
Silarx is the first manufacturer of Loratadine Oral Solution (equivalent to the active ingredient of Claritin) with the FDA approved indication of “Hives-Relief”. Additional key products included in our catalogue are Citalopram Oral Solution (equivalent to the active ingredient of Celexa) and Fluoxetine Oral Solution (equivalent to the active ingredient of Prozac). Our mission is to offer our customers and patients a cost-effective generic alternative to brand medicines while providing therapeutically equivalent products and we are committed to manufacturing therapeutically equivalent, generic drug products to meet the needs of our customers.
iContracts Media Contact:
Anne Ambrosio
iContracts, Inc.
Tel: 908-393-9550
aambrosio@icontracts.com